Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo

Xiaomeng Xie, Kangdong Liu, Feifei Liu, Hanyong Chen, Xiangyu Wang, Xueyin Zu, Xiaoli Ma, Ting Wang, Qiong Wu, Yan Zheng, Ann M. Bode, Zigang Dong, Dong Joon Kim

Research output: Contribution to journalArticle

Abstract

Gossypetin as a hexahydroxylated flavonoid found in many flowers and Hibiscus. It exerts various pharmacological activities, including antioxidant, antibacterial and anticancer activities. However, the anticancer capacity of gossypetin has not been fully elucidated. In this study, gossypetin was found to inhibit anchorage-dependent and -independent growth of esophageal cancer cells. To identify the molecular target(s) of gossypetin, various signaling protein kinases were screened and results indicate that gossypetin strongly attenuates the MKK3/6-p38 signaling pathway by directly inhibiting MKK3 and MKK6 protein kinase activity in vitro. Mechanistic investigations showed that arginine-61 in MKK6 is critical for binding with gossypetin. Additionally, the inhibition of cell growth by gossypetin is dependent on the expression of MKK3 and MKK6. Gossypetin caused G2 phase cell cycle arrest and induced intrinsic apoptosis by activating caspases 3 and 7 and increasing the expression of BAX and cytochrome c. Notably, gossypetin suppressed patient-derived esophageal xenograft tumor growth in an in vivo mouse model. Our findings suggest that gossypetin is an MKK3 and MKK6 inhibitor that could be useful for preventing or treating esophageal cancer.

Original languageEnglish (US)
Pages (from-to)126-136
Number of pages11
JournalCancer Letters
Volume442
DOIs
StatePublished - Feb 1 2019

Fingerprint

Esophageal Neoplasms
Growth
MAP Kinase Kinase 3
gossypetin
In Vitro Techniques
Hibiscus
G2 Phase Cell Cycle Checkpoints
Caspase 7
G2 Phase
Cytochromes c
Flavonoids
Heterografts
Caspase 3
Protein Kinases
Arginine
Antioxidants
Pharmacology
Apoptosis

Keywords

  • Esophageal cancer
  • Gossypetin
  • MKK3/6
  • p38
  • Patient-derived xenograft

PubMed: MeSH publication types

  • Journal Article

Cite this

Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo. / Xie, Xiaomeng; Liu, Kangdong; Liu, Feifei; Chen, Hanyong; Wang, Xiangyu; Zu, Xueyin; Ma, Xiaoli; Wang, Ting; Wu, Qiong; Zheng, Yan; Bode, Ann M.; Dong, Zigang; Kim, Dong Joon.

In: Cancer Letters, Vol. 442, 01.02.2019, p. 126-136.

Research output: Contribution to journalArticle

Xie, Xiaomeng ; Liu, Kangdong ; Liu, Feifei ; Chen, Hanyong ; Wang, Xiangyu ; Zu, Xueyin ; Ma, Xiaoli ; Wang, Ting ; Wu, Qiong ; Zheng, Yan ; Bode, Ann M. ; Dong, Zigang ; Kim, Dong Joon. / Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo. In: Cancer Letters. 2019 ; Vol. 442. pp. 126-136.
@article{c7736026593b4fbb9eb8682a8fdd2d29,
title = "Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo",
abstract = "Gossypetin as a hexahydroxylated flavonoid found in many flowers and Hibiscus. It exerts various pharmacological activities, including antioxidant, antibacterial and anticancer activities. However, the anticancer capacity of gossypetin has not been fully elucidated. In this study, gossypetin was found to inhibit anchorage-dependent and -independent growth of esophageal cancer cells. To identify the molecular target(s) of gossypetin, various signaling protein kinases were screened and results indicate that gossypetin strongly attenuates the MKK3/6-p38 signaling pathway by directly inhibiting MKK3 and MKK6 protein kinase activity in vitro. Mechanistic investigations showed that arginine-61 in MKK6 is critical for binding with gossypetin. Additionally, the inhibition of cell growth by gossypetin is dependent on the expression of MKK3 and MKK6. Gossypetin caused G2 phase cell cycle arrest and induced intrinsic apoptosis by activating caspases 3 and 7 and increasing the expression of BAX and cytochrome c. Notably, gossypetin suppressed patient-derived esophageal xenograft tumor growth in an in vivo mouse model. Our findings suggest that gossypetin is an MKK3 and MKK6 inhibitor that could be useful for preventing or treating esophageal cancer.",
keywords = "Esophageal cancer, Gossypetin, MKK3/6, p38, Patient-derived xenograft",
author = "Xiaomeng Xie and Kangdong Liu and Feifei Liu and Hanyong Chen and Xiangyu Wang and Xueyin Zu and Xiaoli Ma and Ting Wang and Qiong Wu and Yan Zheng and Bode, {Ann M.} and Zigang Dong and Kim, {Dong Joon}",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.canlet.2018.10.016",
language = "English (US)",
volume = "442",
pages = "126--136",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo

AU - Xie, Xiaomeng

AU - Liu, Kangdong

AU - Liu, Feifei

AU - Chen, Hanyong

AU - Wang, Xiangyu

AU - Zu, Xueyin

AU - Ma, Xiaoli

AU - Wang, Ting

AU - Wu, Qiong

AU - Zheng, Yan

AU - Bode, Ann M.

AU - Dong, Zigang

AU - Kim, Dong Joon

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Gossypetin as a hexahydroxylated flavonoid found in many flowers and Hibiscus. It exerts various pharmacological activities, including antioxidant, antibacterial and anticancer activities. However, the anticancer capacity of gossypetin has not been fully elucidated. In this study, gossypetin was found to inhibit anchorage-dependent and -independent growth of esophageal cancer cells. To identify the molecular target(s) of gossypetin, various signaling protein kinases were screened and results indicate that gossypetin strongly attenuates the MKK3/6-p38 signaling pathway by directly inhibiting MKK3 and MKK6 protein kinase activity in vitro. Mechanistic investigations showed that arginine-61 in MKK6 is critical for binding with gossypetin. Additionally, the inhibition of cell growth by gossypetin is dependent on the expression of MKK3 and MKK6. Gossypetin caused G2 phase cell cycle arrest and induced intrinsic apoptosis by activating caspases 3 and 7 and increasing the expression of BAX and cytochrome c. Notably, gossypetin suppressed patient-derived esophageal xenograft tumor growth in an in vivo mouse model. Our findings suggest that gossypetin is an MKK3 and MKK6 inhibitor that could be useful for preventing or treating esophageal cancer.

AB - Gossypetin as a hexahydroxylated flavonoid found in many flowers and Hibiscus. It exerts various pharmacological activities, including antioxidant, antibacterial and anticancer activities. However, the anticancer capacity of gossypetin has not been fully elucidated. In this study, gossypetin was found to inhibit anchorage-dependent and -independent growth of esophageal cancer cells. To identify the molecular target(s) of gossypetin, various signaling protein kinases were screened and results indicate that gossypetin strongly attenuates the MKK3/6-p38 signaling pathway by directly inhibiting MKK3 and MKK6 protein kinase activity in vitro. Mechanistic investigations showed that arginine-61 in MKK6 is critical for binding with gossypetin. Additionally, the inhibition of cell growth by gossypetin is dependent on the expression of MKK3 and MKK6. Gossypetin caused G2 phase cell cycle arrest and induced intrinsic apoptosis by activating caspases 3 and 7 and increasing the expression of BAX and cytochrome c. Notably, gossypetin suppressed patient-derived esophageal xenograft tumor growth in an in vivo mouse model. Our findings suggest that gossypetin is an MKK3 and MKK6 inhibitor that could be useful for preventing or treating esophageal cancer.

KW - Esophageal cancer

KW - Gossypetin

KW - MKK3/6

KW - p38

KW - Patient-derived xenograft

UR - http://www.scopus.com/inward/record.url?scp=85056237638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056237638&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2018.10.016

DO - 10.1016/j.canlet.2018.10.016

M3 - Article

VL - 442

SP - 126

EP - 136

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

ER -